P642: Effect of prior vedolizumab treatment on ustekinumab time-on-treatment in Crohn’s disease: a targeted literature review and statistical analysesECCO'24Year: 2024
Authors: Owen, G.(1)*;Harvey, R.(2);Shields, G.(3);Jenkins, A.(4);Robertson, J.(5);Eaton, J.(4);
(1)Takeda UK Ltd., Market Access, High Wycombe, United Kingdom;(2)Cabourn Statistics, Statistician, Sheffield, United Kingdom;(3)cabourn Statistics, Health Economist, Sheffield, United Kingdom;(4)Takeda UK Ltd, Market Access, London, United Kingdom;(5)Takeda UK Ltd, Medical, London, United Kingdom;
P643: Magnifying Endoscopy with Narrow Band Imaging for Graft Failure and Disease Recurrence in Patients with Crohn’s Disease after Intestinal TransplantationECCO'24Year: 2024
Authors: Chung, C.S.(1)*;Lee, T.H.(2);Tsai, C.C.(3);Yu, C.H.(2);Chen, Y.(4);
(1)Far Eastern Memorial Hospital, Division of Gastroenterology and Hepatology- Department of Internal Medicine, New Taipei City, Taiwan;(2)Far Eastern Memorial Hospital, Department of Internal Medicine, New Taipei City, Taiwan;(3)Far Eastern Memorial Hospital, Department of Anatomical Pathology, New Taipei City, Taiwan;(4)Far Eastern Memorial Hospital, Department of Surgery, New Taipei City, Taiwan;
P644: Body composition does not predict clinical course in patients with acute severe ulcerative colitisECCO'24Year: 2024
Authors: Tassone, D.(1)*;Xu, E.(2);Winata, S.H.L.(2);Hale, P.(2);Basnayake, C.(1,3);Schulberg, J.(1,3);Flanagan, E.(1,3);Wright, E.(1,3);Kamm, M.A.(1,3);Lust, M.(1);Niewiadomski, O.(1);Tambakis, G.(1);Clark, N.(1);Hartley, I.(1,3);De Gregorio, M.(1,3);Sutherland, T.(2,3);Thompson, A.J.(1,3);Connell, W.R.(1,3);Ding , N.S.(1,3);
(1)St Vincent@E@s Hospital Melbourne, Department of Gastroenterology, Fitzroy, Australia;(2)St Vincent@E@s Hospital Melbourne, Department of Medical Imaging, Fitzroy, Australia;(3)The University of Melbourne, Department of Medicine, Parkville, Australia;
P646: Clinical decision support in the prevention of adverse effects associated with immunosuppressive drugs in patients with Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Lobato Matilla, M.E.(1)*;Marin Jimenez, I.(2);Menchén Viso, L.A.(2);Miranda Bautista, J.(2);Chamorro de Vega, E.(1);Romero Jiménez, R.(1);Ferris Villanueva, M.(1);Herranz Alonso, A.(1);Sanjurjo Sáez, M.(1);
(1)H.G.U. Gregorio Marañon, Pharmacy Department, Madrid, Spain;(2)H.G.U. Gregorio Marañon, Gastroenterology, Madrid, Spain;
P647: Effectiveness of combined treatment with two biologics or advanced molecules in inflammatory bowel diseaseECCO'24Year: 2024
Authors: Melcarne, L.(1)*;Laucirica, I.(1);Brunet, E.(1,2);Villoria, A.(1,2,3);Puy, A.(1);Llovet, L.(1);Garcia-Sagué, B.(1);Frisancho, L.E.(1);Altadill, A.(1);López-Sáez, B.(1);Del Estal, J.(4);Calvet, X.(1,2,3);
(1)Parc Taulí Hospital Universitari - Institut d’Investigació i Innovació Parc Taulí I3PT-CERCA, Digestive Disease, Sabadell, Spain;(2)Instituto de Salud Carlos III, CIBERehd, Madrid, Spain;(3)Universitat Autònoma de Barcelona, Medicine, Sabadell, Spain;(4)Parc Taulí Hospital Universitari - Institut d’Investigació i Innovació Parc Taulí I3PT-CERCA, Pharmacy, Sabadell, Spain;
P648: Dietary therapy using a short course of Exclusive Enteral Nutrition followed by the Crohn’s Disease Exclusion Diet in children with mild to severe Crohn’s Disease; maintenance update on the DIETOMICS trialECCO'24Year: 2024
Authors: Sigall-Boneh, R.(1,2)*;Manuel Navas-López, V.(3); Hussey, S.(4);Pujol Muncunill, G.(5);Lawrence, S.(6);Jonsson Rolandsdotter, H.(7,8);Otley, A.(9); Martín-de-Carpi, J.(10);Abramas, L.(11); Herrador López , M.(12);Egea Castillo, N.(13); Chen, M.(14);Hurley, M.(15); Wingate, K.(16);Olen, O.(17,18);Yaakov, M.(19);Wierdsma , N.(20);Van Limbergen, J.(21,22);Wine, E.(23);
(1)Edith Wolfson Medical Center, PIBD Research Center- Pediatric Gastroenterology and Nutrition Unit, Holon, Israel;(2)Tytgat Institute for Liver and Intestinal Research- Academic Medical Center- University of Amsterdam-, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands;(3)Hospital Regional Universitario de Málaga- ., Paediatric Gastroenterology and Nutrition Unit- IBIMA, Málaga, Spain;(4)Royal College of Surgeons of Ireland and University College Dublin, National Children@E@s Research Centre, Dublin, Ireland;(5)Hospital Sant Joan de Déu, Paediatric Gastroenterology- Hepatology and Nutrition Department., Barcelona, Spain;(6)BC Children@E@s Hospital- University of British Columbia-, Pediatric Fastroenterology, Vancouver- BC, Canada;(7)Södersjukhuset- Karolinska Institutet- 11883, Department of Clinical Science and Education, Stockholm-, Sweden;(8)Sachs@E@ Children and Youth Hospital- Södersjukhuset- 11883, Department of Gastroenterology, Stockholm, Sweden;(9)IWK Health Center-, Division of Gastroenterology and Nutrition, Halifax- NS B3K 6R8-, Canada;(10)Hospital Sant Joan de Déu-, Paediatric Gastroenterology- Hepatology and Nutrition Department, Barcelona, Spain;(11)The E. Wolfson Medical Cente, Paediatric Gastroenterology and Nutrition Unit, Holon, Israel;(12)Hospital Regional Universitario de Málaga, Paediatric Gastroenterology and Nutrition Unit- IBIMA-, Málaga- Spain., Spain;(13)Hospital Sant Joan de Déu, Paediatric Gastroenterology- Hepatology and Nutrition Department, Barcelona, Spain;(14)University of Alberta, Departments of Paediatrics and Physiology-, Edmonton- AB T6G 2R3, Canada;(15)hildren’s Health Ireland - Crumlin, Nutrition, Dublin, Ireland;(16)BC Children@E@s Hospital- University of British Columbia-, Nutirion, Vancouver- BC, Canada;(17)Sachs@E@ Children and Youth Hospital- Södersjukhuset-, Department of Gastroenterology, Stockholm, Sweden;(18)Karolinska Institutet, 12. Clinical Epidemiology Division- Department of Medicine Solna, Stockholm, Sweden;(19)The E. Wolfson Medical Center, Pediatric Gastroenterology and Nutrition Unit, Holon, Israel;(20)Amsterdam University Medical Centers, Division of Nutrition and Dietetics, Amsterdam, The Netherlands;(21)Tytgat Institute for Liver and Intestinal Research- - University of Amsterdam-, Amsterdam Gastroenterology Endocrinology and Metabolism- Academic Medical Center, Amsterdam, The Netherlands;(22)Department of Pediatrics- Amsterdam University Medical Centers- Emma Children’s Hospital-, Division of Paediatric Gastroenterology and Nutrition-, Amsterdam, The Netherlands;(23)University of Alberta, Division of Pediatric Gastroenterology- Department of Pediatrics-, Edmonton- AB, Canada;
P649: Long-term follow-up of the PROTDILAT study; LONG-PROTDILAT Prospective multicenter randomized comparative study of endoscopic treatment of strictures in Crohn@E@s disease (CD): self-expandable metal stent (SEMS) vs endoscopic balloon dilatation (EBD).ECCO'24Year: 2024
Authors: Ruiz Ramírez, P.(1,2)*;Loras, C.(1,2);Gornals, J.(3);Maia Bosca-Watts, M.(4);Brunet, E.(5);Iglesias , E.(6);Barrio , J.(7);Sicilia, B.(8);Dueñas, C.(9);Foruny , J.R.(10);Martín-Arranz , M.D.(11);Busquets, D.(12);Cerrillo, E.(13);García Morales, N.(14);Monfort, D.(15);Pérez-Roldán , F.(16);Pijoan , E.(17);González , B.(18);Reyes , J.(19);Torres , G.(20);Maristany , E.(3);Sanchiz , V.(4);Guardiola , J.(21);Esteve , M.(2,22);
(1)Hospital Universitari Mútua Terrassa, Gastroenterology department. Endoscopy Unit, Terrassa, Spain;(2)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Madrid, Spain;(3)Hospital Universitari de Bellvitge, Gastroenterology Department. Endoscopy Unit, Barcelona, Spain;(4)Hospital Clínico Universitario de Valencia, Gastroenterology department, Valencia, Spain;(5)Hospital Universitari Parc Taulí, Gastroenterology department, Sabadell, Spain;(6)Hospital Universitario Reina Sofía, Gastroenterology department, Córdoba, Spain;(7)Hospital Universitario Rio Hortega, Gastroenterology department, Valladolid, Spain;(8)Complejo Asistencial Universitario de Burgos, Gastroenterology department, Burgos, Spain;(9)Hospital San Pedro de Alcántara, Gastroenterology department, Cáceres, Spain;(10)Hospital Universitario Ramón y Cajal, Gastroenterology department, Madrid, Spain;(11)Hospital Universitario La Paz, Gastroenterology department, Madrid, Spain;(12)Hospital Universitari Dr Josep Trueta, Gastroenterology department, Girona, Spain;(13)Hospital Universitario y Politécnico La Fe, Gastroenterology department, Valencia, Spain;(14)Xerencia Xestion Integrada de Vigo- SERGAS, Gastroenterology department, Vigo, Spain;(15)Consorci Sanitari de Terrassa, Gastroenterology department, Terrassa, Spain;(16)Hospital General La Mancha Centro, Gastroenterology department, Ciudad Real, Spain;(17)Clínica Girona, Gastroenterology department, Girona, Spain;(18)Hospital Clínic i Provincial de Barcelona, Gastroenterology department, Barcelona, Spain;(19)Hospital Comarcal d@E@Inca, Gastroenterology department, Inca, Spain;(20)Hospital Universitari Arnau de Vilanova, Gastroenterology department, Lleida, Spain;(21)Hospital Universitari de Bellvitge, Gastroenterology department, Barcelona, Spain;(22)Hospital Universitari Mútua Terrassa, Gastroenterology department, Terrassa, Spain;
P650: Optimization through iv maintenance with ustekinumab in Inflammatory Bowel Disease. Efficacy and adjusted regimen in real world.ECCO'24Year: 2024
Authors: Mínguez, A.(1)*;Coello, E.(1);Gomez, M.(2);Ripoll, P.(1);Garrido, A.(1);Aguas, M.(1);Iborra, M.(1);Cerrillo, E.(1);Tortosa, L.(3);Bayarri, V.(3);Nos, P.(1);Bastida, G.(1);
(1)La Fe University and Polytechnic Hospital, Gastroenterology Department, Valencia, Spain;(2)Complexo Hospitalario Universitario de A Coruña, Department of Gastroenterology, A Coruña, Spain;(3)La Fe University and Polytechnic Hospital, IIS Hospital la Fe. IBD research group, Valencia, Spain;
P651: A randomised controlled trial of IBD-BOOST, a digital cognitive behavioural self-management programme for fatigue, and/or pain, and/or faecal incontinence in inflammatory bowel diseaseECCO'24Year: 2024
Authors: Norton, C.(1)*;Moss Morris, R.(2);Hart, A.(3);Cleirigh Buettner, F.(4);Hamborg, T.(5);Miller, L.(4);Stagg, I.(6);Aziz, Q.(7);Czuber-Dochan, W.(1);Dibley, L.(8);Mihaylova, B.(4);Pollok, R.(9);Roukas, C.(4);Saxena, S.(10);Sweeney, L.(2);Taylor, S.(4);Wileman, V.(2);
(1)King@E@s College London, Florence Nightingale Faculty of Nursing- Midwifery & Palliative Care, London, United Kingdom;(2)King@E@s College London, Institute of Psychiatry- Psychology and Neuroscience, London, United Kingdom;(3)St Mark@E@s Hospital & Imperial College, St Mark@E@s Academic Institute, London, United Kingdom;(4)Queen Mary University of London, Pragmatic Clinical Trials Unit, London, United Kingdom;(5)Queen Mary University of London, Pragmatic Clinical Trails Unit, London, United Kingdom;(6)St. Mark@E@s Hospital, Inflammatory Bowel Disease Unit, London, United Kingdom;(7)Queen Mary University of London, Blizzard Institute, London, United Kingdom;(8)Greenwich University, Centre for Chronic Illness and Ageing, London, United Kingdom;(9)St George Hospital, Gastroenterology, London, United Kingdom;(10)Imperial College London, Primary Care, London, United Kingdom;
P653: Impact of ozanimod on type III collagen turnover biomarkers and the association with ozanimod efficacy in patients with moderately to severely active ulcerative colitis: Results from the phase 3 True North studyECCO'24Year: 2024
Authors: D@E@Haens, G.(1)*;Maddux, R.(2);Wu, C.(2);Hu, Y.(2);Sands, B.E.(3);Mortensen, J.H.(4);Zhang, J.(2);Petersen, A.(2);Harris, S.(2);
(1)Amsterdam University Medical Center- Amsterdam- Netherlands- Department of Gastroenterology and Hepatology- University of Leuven, Gastroenterology and Hepatology, Leuven, Belgium;(2)Bristol Myers Squibb, n/a, Princeton, United States;(3)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(4)Nordic Bioscience, Gastroenterology, Herlev, Denmark;
P654: Assessing patient-perceived burden of disease in Ulcerative Colitis: a novel scoring approach in a real-world Australasian cohortECCO'24Year: 2024
Authors: Gu, B.(1,2)*;Pipicella, J.L.(2,3,4);Palmer, L.(5);Connor, S.J.(1,2,3,4);Wilson, W.(6,7);Andrews, J.M.(4,8,9);
(1)Liverpool Hospital, Gastroenterology and Hepatology, Liverpool, Australia;(2)University of New South Wales, Medicine & Health South Western Sydney Clinical School, Sydney, Australia;(3)Ingham Institute for Applied Medical Research, Gastroenterology- Hepatology and Inflammatory Bowel Disease Research Group, Liverpool, Australia;(4)Crohn@E@s Colitis Cure, CCCure, Pyrmont, Australia;(5)The University of Adelaide, Faculty of Health and Medical Sciences- School of Public Health, Adelaide, Australia;(6)SA Health, Chief Medical Information Officer, Adelaide, Australia;(7)Lyell McEwin Hospital, Anaesthetics, Adelaide, Australia;(8)University of Adelaide, Faculty of Health Sciences, Adelaide, Australia;(9)Central Adelaide Local Health Network, Gastroenterology, Adelaide, Australia;
P655: The ileorectal anastomosis after a total colectomy is a feasible and valid surgical alternative in the treatment of inflammatory bowel diseaseECCO'24Year: 2024
Authors: Tapiolas, I.(1)*;Mañosa, M.(2);Troya, J.(1);Vela, S.(1);Pares, D.(1);Mesonero, F.(3);Valera, P.(4);Riestra, S.(5);Iglesias, E.(6);Rodríguez-González, E.(7);Guardiola, J.(8);García López, S.(9);Carpio, D.(10);Vega, P.(11);Martín Arranz , M.D.(12);Ramos, L.(13);Busquets, D.(14);Sierra, M.(15);Martínez Montiel, P.(16);Sicilia, B.(17);Ricart, E.(18);Garcia Planella , E.(19);Huguet, J.M.(20);Vera, I.(21);Gomollon, F.(22);Rivero, M.(23);De Castro, L.(24);Barreiro de Acosta, M.(25);Rodríguez Lago, I.(26);Gisbert, J.P.(27);Garcia Sepulcre, M.F.(28);Calvet, X.(29);Bermejo, F.(30);Pérez Calle , J.L.(31);Gutierrez, A.(32);Lucendo, A.J.(33);Muñoz Vilafranca, M.D.C.(34);Navarro Llavat, M.(35);Calafat, M.(2);Doménech, E.(2);
(1)Hospital Germans Trias i Pujol, Colorectal surgery, Badalona, Spain;(2)Hospital Germans Trias i Pujol, Gastroenterology, Badalona, Spain;(3)Hospital Universitario Ramon y Cajal, Gastroenterology, Madrid, Spain;(4)Hospital de Cabueñes, Gastroenterology, Gijón, Spain;(5)Hospital Universitario central de Asturias, Gastroenterology, Oviedo, Spain;(6)Hospital Universitario Reina Sofía, Gastroenterology, Madrid, Spain;(7)Hospital Nuestra Señora de la Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain;(8)Hospital Universitari de Bellvitge, Gastroenterology, Barcelona, Spain;(9)Hospital Miguel Servet, Gastroenterology, Zaragoza, Spain;(10)Complexo de Pontevedra, Gastroenterology, Pontevedra, Spain;(11)Complexo H. Universitario de Ourense, Gastroenterology, Ourense, Spain;(12)Hospital Universitario la Paz, Gastroenterology, Madrid, Spain;(13)Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain;(14)Hospital Universitari Josep Trueta, Gastroenterology, Girona, Spain;(15)Complejo Asistencial Universitario de León, Gastroenterology, Leon, Spain;(16)Hospital Universitario 12 de Octubre, Gastroenterology, Madrid, Spain;(17)Hospital de Burgos, Gastroenterology, Burgos, Spain;(18)Hospital Clínic de Barcelona, Gastroenterology, Barcelona, Spain;(19)Hospital Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain;(20)Hospital Universitario General de Valencia, Gastroenterology, Valencia, Spain;(21)Hospital Universitario Puerta de Hierro, Gastroenterology, Majadahonda, Spain;(22)Hospital Clinico Lozano Blesa, Gastroenterology, Zaragoza, Spain;(23)Hospital Marqués de Valdecilla, Gastroenterology, Santander, Spain;(24)Hospital Alvaro Cunqueiro, Gastroenterology, Vigo, Spain;(25)Hospital Universitario de Santiago, Gastroenterology, Santiago de Compostela, Spain;(26)Hospital Galdakao, Gastroenterology, Galdakao, Spain;(27)Hospital de la Princesa, Gastroenterology, Madrid, Spain;(28)Hospital General Universitario de Elche, Gastroenterology, Elche, Spain;(29)Corporació Saitària Parc Taulí, Gastroenterology, Sabadell, Spain;(30)Hospital Universitario de Fuenlabrada, Gastroenterology, Fuenlabrada, Spain;(31)Hospital Universitario Alcorcon, Gastroenterology, Alcorcon, Spain;(32)Hospital General de Alicante, Gastroenterology, Alicante, Spain;(33)Hospital General de Tomelloso, Gastroenterology, Tomelloso, Spain;(34)Hospital de Basurto, Gastroenterology, Basurto, Spain;(35)Hospital Moisés Broggi, Gastroenterology, Sant Joan Despí, Spain;ENEIDA
P656: Plasma Inflammation-related Proteins Predict the Therapeutic Effect of 5-ASA in Patients with Ulcerative ColitisECCO'24Year: 2024
Authors: Dang, Y.(1)*;Xu, X.(1);Zhou, M.(1);Xu, C.(1);Huang, X.(1);Xu, F.(1);Wang, Z.(1);Wang, C.(1);Zhu, S.(1);Li, P.(1);Zhang, S.(1);Shi, H.(1);
(1)Capital Medical University- Beijing Friendship Hospital, Department of gastroenterology, Beijing, China;
P657: Persistence of subcutaneous infliximab after two years of the switch from intravenous infliximab to subcutaneous infliximab in Inflammatory Bowel Disease patientsECCO'24Year: 2024
Authors: Huguet, J.M.(1)*;Iborra, M.(2);Marti, L.(3);Bosca-Watts, M.M.(4);Ramirez, J.J.(5);Ruiz, L.(1);Sanchis, L.(6);Garrido, A.(2);Alemany, G.(3);Suria, C.(4);Paredes, J.M.(7);
(1)Hospital General Universitario de Valencia, Gastroenterology, Valencia, Spain;(2)Hospital Universitari i Politecnic la Fe de Valencia, Gastroenterology, Valencia, Spain;(3)Hospital Francesc de Borja de Gandia, Gastroenterology, Valencia, Spain;(4)Hospital Clinico Universitario de Valencia, Gastroenterology, Valencia, Spain;(5)Hospital Lluis Alcanyis de Xativa, Gastroenterology, Valencia, Spain;(6)Hospital de Sagunto, Gastroenterology, Valencia, Spain;(7)Hospital Universitario Dr. Peset de Valencia, Gastroenterology, Valencia, Spain;
P658: Safety and efficacy of MH002, an optimized live biotherapeutic product, for the treatment of mild to moderate ulcerative colitis: a first-in-disease, double-blind, randomized clinical trialECCO'24Year: 2024
Authors: Vermeire, S.(1)*;Dewint, P.(2);Vansteelant, M.(2);Peterka, M.(3);Štěpek, D.(4);Kierkuś, J.(5);Wiernicka, A.(5);Napora, P.(6);Wolański , Ł.(7);Kopoń, A.(8);Magro, F.(9);Pinheiro, I.(10);Possemiers, S.(10);Haazen, L.(10);Bolca, S.(10);
(1)University hospitals Leuven, Department of Gastroenterology & Hepatology, Leuven, Belgium;(2)AZ Maria Middelares Gent, Department of Gastroenterology, Ghent, Belgium;(3)Nemocnice Slany, Gastroenterologická a hepatologická ambulance, Slany, Czech Republic;(4)Vojenska nemocnice Brno, Interni oddeleni, Brno, Czech Republic;(5)The Children’s Memorial Health Institute, Department of Gastroenterology- Hepatology- Feeding Disorders and Pediatrics, Warsaw, Poland;(6)Centrum Badań Klinicznych, Gastroenterology, Wroclaw, Poland;(7)Samodzielny Publiczny Zakład Opieki Zdrowotnej w Łęcznej, Oddział Gastroenterologiczny, Łęczna, Poland;(8)Centrum Gastrologii I Endoskopii, Gastromed, Toruń, Poland;(9)Faculty of Medicine of the University of Porto, Cintesis@RISE, Porto, Portugal;(10)MRM Health NV, Research & Development, Zwijnaarde, Belgium;
P659: Prognostic markers in Treat-to-Target for Crohn’s Disease- an Asian institution’s experienceECCO'24Year: 2024
Authors: Jiang, B.(1)*;Leong, J.(1);Ong, J.(1);Ang, T.L.(1);Wang, L.M.(2);Tan, C.K.(1);
(1)Changi General Hospital, Gastroenterology and Hepatology, Singapore, Singapore;(2)Changi General Hospital, Pathology, Singapore, Singapore;
P660: Serum Leucine-rich Alpha-2 Glycoprotein Can be a Biomarker for Selecting Anti-Cytokine Biologics in Patients with Inflammatory Bowel Disease: A Multicentre Prospective Cohort StudyECCO'24Year: 2024
Authors: Amano, T.(1)*;Yoshihara, T.(1);Shinzaki, S.(2);Sakakibara, Y.(3);Yamada, T.(4);Osugi, N.(5);HIyama, S.(6);Murayama, Y.(7);Ogiyama, H.(8);Nagaike, K.(9);Tujii, Y.(1);Asakura, A.(1);Tashiro, T.(1);Tani, M.(1);Otake-Kasamoto, Y.(1);Inoue, T.(1);Yonezawa, A.(10);Iijima, H.(11);Hayashi, Y.(1);Takehara, T.(1);
(1)Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Suita, Japan;(2)Hyogo Medical University, Department of Gastroenterology, Nishinomiya, Japan;(3)National Hospital Organization Osaka National Hospital, Department of Gastroenterology, Osaka, Japan;(4)Osaka Rosai Hospital, Department of Gastroenterology and Hepatology, Sakai, Japan;(5)Toyonaka Municipal Hospital, Department of Gastroenterology, Toyonaka, Japan;(6)Japan Community Healthcare Organization Osaka Hospital, Department of Gastroenterology, Osaka, Japan;(7)Itami City Hospital, Department of Gastroenterology and Hepatology, Itami, Japan;(8)Ikeda Municipal Hospital, Department of Gastroenterology, Ikeda, Japan;(9)Suita Municipal Hospital, Department of Gastroenterology and Hepatology, Suita, Japan;(10)Keio University, Division of Integrative Clinical Pharmacology- Faculty of Pharmacy, Tokyo, Japan;(11)Osaka Police Hospital, Department of Internal Medicine, Osaka, Japan;the Osaka Gut Forum
P661: Ustekinumab in Crohn’s disease: A three-year multicentre prospective study from Hungary - Assessing efficacy, drug sustainability, and safetyECCO'24Year: 2024
Authors: Barkai, L.J.(1)*;Gonczi, L.(1);Farkas, K.(2);Farkas, B.(2);Molnar, T.(2);Szamosi, T.(3);Schafer, E.(3);Golovics, P.(3);Juhasz, M.(4);Patai, A.(5);Vincze, A.(6);Sarlos, P.(6);Farkas, A.(7);Dubravcsik, Z.(7);Toth, T.G.(8);Miheller, P.(9);LakatosPhD, P.L.(10);Ilias, A.(1);
(1)Semmelweis University, Department of Medicine and Oncology, Budapest, Hungary;(2)University of Szeged, Department of Medicine, Szeged, Hungary;(3)Medical Centre- Hungarian Defence Forces, Department of Gastroenterology, Budapest, Hungary;(4)St. Margit Hospital, Department of Medicine, Budapest, Hungary;(5)Markusovszky Hospital, Department of Medicine and Gastroenterology, Szombathely, Hungary;(6)Medical School- University of Pecs, First Department of Medicine, Pecs, Hungary;(7)Bács-Kiskun County Hospital, Department of Gastroenterology, Kecskemet, Hungary;(8)St. Janos Hospital, Department of Gastroenterology, Budapest, Hungary;(9)Semmelweis University, Department of Surgery- Transplantation and Gastroenterology, Budapest, Hungary;(10)Mcgill University Health Center, IBD Centre, Montréal, Canada;
P662: Discontinuation of biologic therapy in Inflammatory Bowel Disease: longer term outcomes.ECCO'24Year: 2024
Authors: Al-Talib, I.(1)*;Iqbal, M.(1);Slater, J.(1);Bates, B.(1);Jones, J.(1);Rattehalli, D.(1);King, D.(1);De Silva, S.(1);
(1)The Dudley Group NHS Foundation Trust, Gastroenterology, Dudley, United Kingdom;
